("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

These programs "are no replacement for real policy. Everyone deserves consistent access to affordable insulin," said Shaina Kasper, executive director of advocacy group T1 International.

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

These programs "are no replacement for real policy. Everyone deserves consistent access to affordable insulin," said Shaina Kasper, executive director of advocacy group T1 International.

("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and ...